The role of the pharmacist in the treatment of asthma – it’s not just the drug that matters Review article

Main Article Content

Marek Postuła

Abstract

Appropriate selection and correct use of inhalation devices is an integral component in the management of asthma and chronic obstructive pulmonary disease. It is well known that there are many challenges with the use of inhalers, and no one device suits all patients. Importantly, education and support is crucial, not only to enable patients to recognize the need for optimal disease management, but also to help them develop good inhaler technique. In addition, health care professionals should also aim to increase their knowledge of the devices they prescribe and develop systems to ensure that they offer comprehensive support to patients in clinical practice.

Article Details

How to Cite
Postuła , M. (2020). The role of the pharmacist in the treatment of asthma – it’s not just the drug that matters. Medycyna Faktow (J EBM), 13(4(49), 442-444. https://doi.org/10.24292/01.MF.0420.8
Section
Articles

References

1. Bonini M, Usmani OS. The importance of inhaler devices in the treatment of COPD. COPD Res Pract. 2015; 1(1): 9.
2. Lavorini F, Corrigan CJ, Barnes PJ et al. Aerosol Drug Management Improvement Team. Retail sales of inhalation devices in European countries: so much for a global policy. Respir Med. 2011; 105(7): 1099-103.
3. Ari A, Fink JB. Guidelines for aerosol devices in infants, children and adults: which to choose, why and how to achieve effective aerosol therapy. Expert Rev Respir Med. 2011; 5(4): 561-72.
4. Westerik JA, Carter V, Chrystyn H et al. Characteristics of patients making serious inhaler errors with a dry powder inhaler and association with asthma-related events in a primary care setting. J Asthma. 2016; 53(3): 321-9.
5. Levy ML, Hardwell A, McKnight E et al. Asthma patients’ inability to use a pressurised metered-dose inhaler (pMDI) correctly correlates with poor asthma control as defined by the global initiative for asthma (GINA) strategy: a retrospective analysis. Prim Care Respir J. 2013; 22(4): 406-11.
6. Hodder R, Price D. Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat Soft Mist inhaler. Int J Chron Obstruct Pulmon Dis. 2009; 4: 381-90.
7. Bonini M, Usmani OS. The importance of inhaler devices in the treatment of COPD. COPD Res Pract. 2015; 1(1): 9.
8. Inhaler Error Steering Committee, Price D, Bosnic-Anticevich S et al. Inhaler competence in asthma: common errors, barriers to use and recommended solutions. Respir Med. 2013; 107(1): 37-46.
9. Lavorini F, Usmani OS. Correct inhalation technique is critical in achieving good asthma control. Prim Care Respir J. 2013; 22(4): 385-6.
10. Small M, Anderson P, Vickers A et al. Importance of inhaler-device satisfaction in asthma treatment: real-world observations of physician-observed compliance and clinical/patient-reported outcomes. Adv Ther. 2011; 28(3): 202-12.
11. Lavorini F, Levy ML, Corrigan C et al; ADMIT Working Group. The ADMIT series – issues in inhalation therapy. 6) Training tools for inhalation devices. Prim Care Respir J. 2010; 19(4): 335-41.
12. Normansell R, Kew KM, Mathioudakis AG. Interventions to improve inhaler technique for people with asthma. Cochrane Database Syst Rev. 2017; 3: CD012286.
13. Bosnic-Anticevich SZ, Sinha H, So S et al. Metered-dose inhaler technique: the effect of two educational interventions delivered in community pharmacy over time. J Asthma. 2010; 47(3): 251-6.
14. Goodwin R, Heraghty J. Do healthcare professionals understand asthma devices? Arch Dis Child Educ Pract Ed. 2015; 100(6): 302-5.